Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

Standard

Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria : evaluation of 154 patients. / Ghazanfar, M N; Sand, C; Thomsen, S F.

I: British Journal of Dermatology, Bind 175, Nr. 2, 2016, s. 404-6.

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

Harvard

Ghazanfar, MN, Sand, C & Thomsen, SF 2016, 'Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients', British Journal of Dermatology, bind 175, nr. 2, s. 404-6. https://doi.org/10.1111/bjd.14540

APA

Ghazanfar, M. N., Sand, C., & Thomsen, S. F. (2016). Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients. British Journal of Dermatology, 175(2), 404-6. https://doi.org/10.1111/bjd.14540

Vancouver

Ghazanfar MN, Sand C, Thomsen SF. Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients. British Journal of Dermatology. 2016;175(2):404-6. https://doi.org/10.1111/bjd.14540

Author

Ghazanfar, M N ; Sand, C ; Thomsen, S F. / Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria : evaluation of 154 patients. I: British Journal of Dermatology. 2016 ; Bind 175, Nr. 2. s. 404-6.

Bibtex

@article{15081bfac63e4310991a941a301963ea,
title = "Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients",
keywords = "Letter",
author = "Ghazanfar, {M N} and C Sand and Thomsen, {S F}",
year = "2016",
doi = "10.1111/bjd.14540",
language = "English",
volume = "175",
pages = "404--6",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria

T2 - evaluation of 154 patients

AU - Ghazanfar, M N

AU - Sand, C

AU - Thomsen, S F

PY - 2016

Y1 - 2016

KW - Letter

U2 - 10.1111/bjd.14540

DO - 10.1111/bjd.14540

M3 - Letter

VL - 175

SP - 404

EP - 406

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 2

ER -

ID: 167805305